Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies

      Graphical Abstract

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hanrath Aidan T.
        • Payne Brendan A.I.
        • Duncan Christopher J.A.
        Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.
        J Infect. 2020; (Dec 26)https://doi.org/10.1016/j.jinf.2020.12.023
        • Breathnach Aodhán Seán
        • Riley Peter Andrew
        • Cotter Meaghan Patricia
        • Houston Angela Cara
        • Habibi Maximillian Shahin
        • Planche Timothy David
        Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
        J Infect. 2021; 82 (AprPublished online 2021 Jan 13): e11-e12https://doi.org/10.1016/j.jinf.2021.01.005
        • Hall Victoria Jane
        • Foulkes Sarah
        • Charlett Andre
        • Atti Ana
        • Monk Edward J M
        • Simmons Ruth
        • Wellington Edgar
        • Cole Michelle J
        • Saei Ayoub
        • Oguti Blanche
        • Munro Katie
        • Wallace Sarah
        • Kirwan Peter D
        • Shrotri Madhumita
        • Vusirikala Amoolya
        • Rokadiya Sakib
        • Kall Meaghan
        • Zambon Maria
        • Ramsay Mary
        • Brooks Tim
        • Brown Colin S
        • Chand Meera A
        • Hopkins Susan
        SIREN Study Group. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
        Lancet. 2021; 397: 1459-1469
        • Holm Hansen Christian
        • Michlmayr Daniela
        • Gubbels Sophie Madeleine
        • Mølbak Kåre
        • Ethelberg Steen
        Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.
        Lancet. 2021; 397: 1204-1212
        • Lumley SF
        • O'Donnell D
        • Stoesser NE
        • Matthews PC
        • Howarth A
        • Hatch SB
        • Marsden BD
        • Cox S
        • James T
        • Warren F
        • Peck LJ
        • Ritter TG
        • de Toledo Z
        • Warren L
        • Axten D
        • Cornall RJ
        • Jones EY
        • Stuart DI
        • Screaton G
        • Ebner D
        • Hoosdally S
        • Chand M
        • Crook DW
        • O'Donnell AM
        • Conlon CP
        • Pouwels KB
        • Walker AS
        • Peto TEA
        • Hopkins S
        • Walker TM
        • Jeffery K
        • Eyre DW
        Oxford University Hospitals Staff Testing Group. antibody status and incidence of SARS-CoV-2 infection in health care workers.
        N Engl J Med. 2021; 384 (Feb 11): 533-540https://doi.org/10.1056/NEJMoa2034545
        • Quinti I
        • Lougaris V
        • Milito C
        • Cinetto F
        • Pecoraro A
        • Mezzaroma I
        • Mastroianni CM
        • Turriziani O
        • Bondioni MP
        • Filippini M
        • Soresina A
        • Spadaro G
        • Agostini C
        • Carsetti R
        • Plebani A.
        A possible role for B cells in COVID-19? lesson from patients with agammaglobulinemia.
        J Allergy Clin Immunol. 2020; 146 (JulEpub 2020 Apr 22): 211-213.e4https://doi.org/10.1016/j.jaci.2020.04.013
        • Montero-Escribano P
        • Matías-Guiu J
        • Gómez-Iglesias P
        • Porta-Etessam J
        • Pytel V
        • Matias-Guiu JA.
        Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: a case series of 60 patients from Madrid, Spain.
        Mult Scler Relat Disord. 2020; 42 (JulEpub 2020 May 7)102185https://doi.org/10.1016/j.msard.2020.102185
        • Schwarzkopf S
        • Krawczyk A
        • Knop D
        • Klump H
        • Heinold A
        • Heinemann FM
        • Thümmler L
        • Temme C
        • Breyer M
        • Witzke O
        • Dittmer U
        • Lenz V
        • Horn PA
        • Lindemann M.
        Cellular immunity in COVID-19 Convalescents with PCR-confirmed infection but with undetectable SARS-CoV-2-specific IgG.
        Emerg Infect Dis. 2021; 27 (Jan)
        • Rydyznski Moderbacher C
        • Ramirez SI
        • Dan JM
        • Grifoni A
        • Hastie KM
        • Weiskopf D
        • Belanger S
        • Abbott RK
        • Kim C
        • Choi J
        • Kato Y
        • Crotty EG
        • Kim C
        • Rawlings SA
        • Mateus J
        • Tse LPV
        • Frazier A
        • Baric R
        • Peters B
        • Greenbaum J
        • Ollmann Saphire E
        • Smith DM
        • Sette A
        • Crotty S.
        Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity.
        Cell. 2020; 183: 996-1012
        • Russell MW
        • Moldoveanu Z
        • Ogra PL
        • Mestecky J.
        Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection.
        Front Immunol. 2020; 11 (Published 2020 Nov 30)611337https://doi.org/10.3389/fimmu.2020.611337
        • Dan JM
        • Mateus J
        • Kato Y
        • Hastie KM
        • Yu ED
        • Faliti CE
        • Grifoni A
        • Ramirez SI
        • Haupt S
        • Frazier A
        • Nakao C
        • Rayaprolu V
        • Rawlings SA
        • Peters B
        • Krammer F
        • Simon V
        • Saphire EO
        • Smith DM
        • Weiskopf D
        • Sette A
        • Crotty S.
        Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
        Science. 2021; 371 (Epub 2021 Jan 6): eabf4063https://doi.org/10.1126/science.abf4063
      1. Hartley GE, Edwards ESJ, Aui PM, Varese N, Stojanovic S, McMahon J, Peleg AY, Boo I, Drummer HE, Hogarth PM, O'Hehir RE, van Zelm MC. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence. Sci Immunol. 2020 Dec 22;5(54):eabf8891. doi: 10.1126/sciimmunol.abf8891

        • Rosado MM
        • Scarsella M
        • Pandolfi E
        • Cascioli S
        • Giorda E
        • Chionne P
        • Madonne E
        • Gesualdo F
        • Romano M
        • Ausiello CM
        • Rapicetta M
        • Zanetti AR
        • Tozzi A
        • Carsetti R.
        Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example.
        Eur J Immunol. 2011; 41 (Epub 2011 May): 1800-1808https://doi.org/10.1002/eji.201041187